Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Invest ; 131(9)2021 05 03.
Artigo em Inglês | MEDLINE | ID: mdl-33938449

RESUMO

The melanocortin 4 receptor (MC4R) plays a critical role in the long-term regulation of energy homeostasis, and mutations in the MC4R are the most common cause of monogenic obesity. However, the precise molecular and cellular mechanisms underlying the maintenance of energy balance within MC4R-expressing neurons are unknown. We recently reported that the MC4R localizes to the primary cilium, a cellular organelle that allows for partitioning of incoming cellular signals, raising the question of whether the MC4R functions in this organelle. Here, using mouse genetic approaches, we found that cilia were required specifically on MC4R-expressing neurons for the control of energy homeostasis. Moreover, these cilia were critical for pharmacological activators of the MC4R to exert an anorexigenic effect. The MC4R is expressed in multiple brain regions. Using targeted deletion of primary cilia, we found that cilia in the paraventricular nucleus of the hypothalamus (PVN) were essential to restrict food intake. MC4R activation increased adenylyl cyclase (AC) activity. As with the removal of cilia, inhibition of AC activity in the cilia of MC4R-expressing neurons of the PVN caused hyperphagia and obesity. Thus, the MC4R signaled via PVN neuron cilia to control food intake and body weight. We propose that defects in ciliary localization of the MC4R cause obesity in human inherited obesity syndromes and ciliopathies.


Assuntos
Peso Corporal , Encéfalo/metabolismo , Cílios/metabolismo , Ingestão de Alimentos , Neurônios/metabolismo , Receptor Tipo 4 de Melanocortina/metabolismo , Transdução de Sinais , Animais , Cílios/genética , Metabolismo Energético , Camundongos , Camundongos Transgênicos , Receptor Tipo 4 de Melanocortina/genética
2.
PLoS One ; 13(3): e0194591, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29547667

RESUMO

OBJECTIVE: Osteoarthritis (OA) is characterized by cartilage degradation but also by other joint tissues modifications like subchondral bone sclerosis. In this study, we used a proteomic approach to compare secretome of osteoblast isolated from sclerotic (SC) or non sclerotic (NSC) area of OA subchondral bone. DESIGN: Secretome was analyzed using differential quantitative and relative label free analysis on nanoUPLC G2 HDMS system. mRNA of the more differentially secreted proteins were quantified by RT-PCR in cell culture from 5 other patients. Finally, osteomodulin and fibulin-3 sequences were quantified by western blot and immunoassays in serum and culture supernatants. RESULTS: 175 proteins were identified in NSC osteoblast secretome. Data are available via ProteomeXchange with identifier PXD008494. Compared to NSC osteoblast secretome, 12 proteins were significantly less secreted (Osteomodulin, IGFBP5, VCAM-1, IGF2, 78 kDa glucose-regulated protein, versican, calumenin, IGFBP2, thrombospondin-4, periostin, reticulocalbin 1 and osteonectin), and 13 proteins were significantly more secreted by SC osteoblasts (CHI3L1, fibulin-3, SERPINE2, IGFBP6, SH3BGRL3, SERPINE1, reticulocalbin3, alpha-2-HS-glycoprotein, TIMP-2, IGFBP3, TIMP-1, SERPINF1, CSF-1). Similar changes in osteomodulin, IGF2, SERPINE1, fibulin-3 and CHI3L1 mRNA levels were observed. ELISAs assays confirm the decrease by half of osteomodulin protein in SC osteoblasts supernatant compared to NSC and in OA patients serum compared to healthy subjects. Fibulin-3 epitopes Fib3-1, Fib3-2 and Fib3-3 were also increased in SC osteoblasts supernatant compared to NSC. CONCLUSIONS: We highlighted some proteins differentially secreted by the osteoblasts coming from OA subchondral bone sclerosis. These changes contribute to explain some features observed in OA subchondral bone, like the increase of bone remodeling or abnormalities in bone matrix mineralization. Among identified proteins, osteomodulin was found decreased and fibulin-3 increased in serum of OA patients. These findings suggest that osteomodulin and fibulin-3 fragments could be biomarkers to monitor early changes in subchondral bone metabolism in OA.


Assuntos
Osso e Ossos/metabolismo , Proteínas da Matriz Extracelular/metabolismo , Osteoartrite do Joelho/patologia , Osteoblastos/metabolismo , Osteosclerose/patologia , Proteoglicanas/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/análise , Remodelação Óssea/fisiologia , Osso e Ossos/citologia , Osso e Ossos/patologia , Calcificação Fisiológica , Células Cultivadas , Ensaio de Imunoadsorção Enzimática , Humanos , Masculino , Pessoa de Meia-Idade , Osteoartrite do Joelho/diagnóstico , Projetos Piloto , Proteômica , RNA Mensageiro/metabolismo
3.
BMC Vet Res ; 13(1): 395, 2017 Dec 20.
Artigo em Inglês | MEDLINE | ID: mdl-29262825

RESUMO

BACKGROUND: We have previously demonstrated that a mixture of Curcuminoids extract, hydrolyzed COllagen and green Tea extract (CCOT) inhibited inflammatory and catabolic mediator's synthesis by bovine and human chondrocytes. A randomly allocated, double-blind, prospective, placebo-controlled study was performed to evaluate the efficacy of a diet containing this CCOT mixture on dogs with naturally occurring osteoarthritis (OA). Therefore, 42 owner's dogs with OA were randomly assigned to receive for 3 months an experimental diet (control) or the same diet supplemented with CCOT. RESULTS: Ground reaction forces did not show statistical differences between groups. After 3 months of feeding, there was a significant reduction of pain at manipulation in the CCOT group, but not in the control group. The evolution for pain at manipulation depended on the diet. The three other parameters evaluated by veterinary subjective assessment (lameness, pain at palpation and joint mobility) did not show statistical differences. Concerning owner subjective assessment, pain severity score worsened in the control group but remained stable in CCOT group. The evolution for pain severity depended on the diet. No statistical difference was found for pain interference, except for the ability to rise to standing from lying down, which was significantly improved in the CCOT compared to the control group. Serum OA biomarkers did not show statistical differences. CONCLUSIONS: Objective variables measured, such as ground reaction forces and OA biomarkers, did not show statistical differences. However, indicators of pain appeared reduced in dogs receiving CCOT mixture for 3 months. The difference of evolution between groups suggests that a greater number of dogs may be necessary to reach a stronger effect on other parameters.


Assuntos
Colágeno/uso terapêutico , Curcuma , Doenças do Cão/tratamento farmacológico , Osteoartrite/veterinária , Extratos Vegetais/uso terapêutico , Chá , Animais , Colágeno/administração & dosagem , Dieta/veterinária , Suplementos Nutricionais , Cães , Método Duplo-Cego , Feminino , Masculino , Osteoartrite/tratamento farmacológico , Extratos Vegetais/administração & dosagem , Estudos Prospectivos
4.
Cartilage ; 8(3): 211-233, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28618869

RESUMO

Objective Osteoarthritis (OA) is one of the leading causes of disability within the adult population. Currently, its diagnosis is mainly based on clinical examination and standard radiography. To date, there is no way to detect the disease at a molecular level, before the appearance of structural changes and symptoms. So an attractive alternative for monitoring OA is the measurement of biochemical markers in blood, urine, or synovial fluid, which could reflect metabolic changes in joint tissue and therefore disease onset and progression. Animal models are relevant to investigate the early stage of OA and metabolic changes occurring in joint tissues. The goal of this narrative review is to summarize the scientific data available in the literature on soluble biomarkers in animal models of OA. Design A literature search was conducted using the PubMed/Medline and Scopus databases between February 1995 and December 2015. All original articles, systematic and narrative reviews published in French or in English were considered. Results We summarized the data of 69 studies and proposed a classification scheme for OA biomarkers in animal studies, largely inspired by the BIPEDS classification. Conclusions Studies about biomarkers and animal models indicate that some markers could be valuable to monitor OA progression and assess therapeutic response in some animal models.

5.
Biomed Mater Eng ; 28(s1): S209-S215, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28372297

RESUMO

Osteoarthritis (OA) is a painful, degenerative and inflammatory disease that affects the entire synovial joints. Nowadays, no cure exists, and the pharmacological treatments are limited to symptoms alleviation. There is a need for a new efficient and safe treatment. Viscosupplementation is a process that aims to restore the normal rheological properties of synovial fluid. For the past years, hyaluronic acid was usually used but this molecule has some limitations including the short residency time in joint cavity. Recently, in vitro studies have suggested that chitosan could promote the expression of cartilage matrix components and reduce inflammatory and catabolic mediator's production by chondrocytes. In vivo, chitosan prevented cartilage degradation and synovial membrane inflammation in OA induced rabbit model. Several studies have also shown that chitosan could induce chondrogenic differentiation of mesenchymal stem cells. Therefore, chitosan is an interesting polymer to design scaffold and hydrogel for cartilage lesion repair, cells transplantation, sustained drug release and viscosupplementation.


Assuntos
Quitosana/uso terapêutico , Osteoartrite/terapia , Viscossuplementação/métodos , Animais , Cartilagem Articular/efeitos dos fármacos , Cartilagem Articular/patologia , Quitosana/química , Condrogênese/efeitos dos fármacos , Humanos , Transplante de Células-Tronco Mesenquimais , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/efeitos dos fármacos , Osteoartrite/patologia , Membrana Sinovial/efeitos dos fármacos , Membrana Sinovial/patologia , Engenharia Tecidual/métodos
6.
PLoS One ; 11(6): e0156902, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27275599

RESUMO

OBJECTIVE: We have previously demonstrated that a mixture of curcuminoids extract, hydrolyzed collagen and green tea extract (COT) inhibited inflammatory and catabolic mediator's synthesis by osteoarthritic human chondrocytes. The objective of this study was to identify new targets of COT using genomic and proteomic approaches. DESIGN: Cartilage specimens were obtained from 12 patients with knee osteoarthritis. Primary human chondrocytes were cultured in monolayer until confluence and then incubated for 24 or 48 hours in the absence or in the presence of human interleukin(IL)-1ß (10-11M) and with or without COT, each compound at the concentration of 4 µg/ml. Microarray gene expression profiling between control, COT, IL-1ß and COT IL-1ß conditions was performed. Immunoassays were used to confirm the effect of COT at the protein level. RESULTS: More than 4000 genes were differentially expressed between conditions. The key regulated pathways were related to inflammation, cartilage metabolism and angiogenesis. The IL-1ß stimulated chemokine ligand 6, matrix metalloproteinase-13, bone morphogenetic protein-2 and stanniocalcin1 gene expressions and protein productions were down-regulated by COT. COT significantly decreased stanniocalcin1 production in basal condition. Serpin E1 gene expression and protein production were down-regulated by IL-1ß. COT reversed the inhibitory effect of IL-1ß. Serpin E1 gene expression was up-regulated by COT in control condition. CONCLUSION: The COT mixture has beneficial effect on osteoarthritis physiopathology by regulating the synthesis of key catabolic, inflammatory and angiogenesis factors. These findings give a scientific rationale for the use of these natural ingredients in the management of osteoarthritis.


Assuntos
Condrócitos/metabolismo , Colágeno/química , Regulação da Expressão Gênica/efeitos dos fármacos , Osteoartrite/metabolismo , Extratos Vegetais/farmacologia , Hidrolisados de Proteína/farmacologia , Chá/química , Idoso , Células Cultivadas , Condrócitos/patologia , Feminino , Glicoproteínas/biossíntese , Humanos , Interleucina-1beta/biossíntese , Masculino , Metaloproteinase 13 da Matriz/biossíntese , Metaloproteinase 2 da Matriz/biossíntese , Pessoa de Meia-Idade , Osteoartrite/tratamento farmacológico , Osteoartrite/patologia , Extratos Vegetais/química , Inibidor 1 de Ativador de Plasminogênio/biossíntese , Hidrolisados de Proteína/química
7.
PLoS One ; 10(3): e0121654, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25799427

RESUMO

The main objective of this study was to assess the in vitro effects of curcuminoids extract, hydrolyzed collagen and green tea extract in normal bovine chondrocytes and osteoarthritic human chondrocytes cultured in monolayer. This study also investigated the synergic or additive effects of these compounds. Enzymatically isolated primary bovine or human chondrocytes were cultured in monolayer until confluence and then incubated for 24 hours or 48 hours in the absence or in the presence of interleukin-1ß and with or without curcuminoids extract, hydrolyzed collagen or green tea extract, added alone or in combination, at different concentrations. Cell viability was neither affected by these compounds, nor by interleukin 1ß. In the absence of interleukin-1ß, compounds did not significantly affect bovine chondrocytes metabolism. In human chondrocytes and in the absence of interleukin 1ß, curcuminoids extract alone or in combination with hydrolyzed collagen and green tea extract significantly inhibited matrix metalloproteinase-3 production. In interleukin-1ß-stimulated bovine chondrocytes, interleukin-6, inducible nitric oxide synthase, cyclooxygenase2, matrix metalloproteinase 3, a disintegrin and metalloproteinase with thrombospondin type I motifs 4 and a disintegrin and metalloproteinase with thrombospondin type I motifs 5 expressions were decreased by curcuminoids extract alone or in combination with hydrolyzed collagen and green tea extract. The combination of the three compounds was significantly more efficient to inhibit interleukin-1ß stimulated matrix metalloproteinase-3 expression than curcuminoids extract alone. In interleukin-1ß-stimulated human chondrocytes, nitric oxide, interleukin-6 and matrix metalloproteinase 3 productions were significantly reduced by curcuminoids extract alone or in combination with hydrolyzed collagen and green tea extract. These findings indicate that a mixture of curcuminoids extract, hydrolyzed collagen and green tea extract has beneficial effects on chondrocytes culture in inflammatory conditions and provide a preclinical basis for the in vivo testing of this mixture.


Assuntos
Condrócitos/efeitos dos fármacos , Colágeno/química , Curcumina/farmacologia , Mediadores da Inflamação/metabolismo , Osteoartrite do Joelho/patologia , Extratos Vegetais/farmacologia , Chá/química , Animais , Anti-Inflamatórios/farmacologia , Bovinos , Condrócitos/citologia , Condrócitos/metabolismo , Condrócitos/patologia , Curcumina/química , Sinergismo Farmacológico , Humanos , Hidrólise , Interleucina-1beta/metabolismo , Interleucina-1beta/farmacologia , Masculino , NF-kappa B/metabolismo , Transdução de Sinais/efeitos dos fármacos
8.
Cytotherapy ; 16(11): 1511-1518, 2014 11.
Artigo em Inglês | MEDLINE | ID: mdl-25174737

RESUMO

This article has been removed: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been removed at the request of the Editor in Chief. This retraction comes after a thorough investigation of the scientific research presented in the article, along with an investigation into the authorship of the article and the ownership of the data presented. The Editor in Chief's decision to retract the article is based upon the authors' misuse and misrepresentation of a peer's scientific data without consent or approval.


Assuntos
Fígado/efeitos dos fármacos , Fígado/metabolismo , Transplante de Células-Tronco Mesenquimais , Cordão Umbilical/citologia , Animais , Células da Medula Óssea/citologia , Células da Medula Óssea/metabolismo , Tetracloreto de Carbono/toxicidade , Humanos , Fígado/lesões , Regeneração Hepática , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/efeitos dos fármacos , Camundongos , Cordão Umbilical/metabolismo , Cordão Umbilical/transplante
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...